Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NEUE Stock Forecast 2026-2027
$6.75
Current Price
$60.94M
Market Cap
Buy 0
Hold 1
Sell 1
Wall St Analyst Ratings
Distance to NEUE Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
NEUE Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
-0.7%
1 Year Change
0.0%
Year-to-Date Change
-11.8%
From 52W High of $7.66
+78.2%
From 52W Low of $3.79
📊 TOP ANALYST CALLS
Did NEUE Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if NeueHealth is one of their latest high-conviction picks.
Latest NEUE Stock Price Targets & Analyst Predictions
NEUE has shown a year-to-date change of 0.0% and a 1-year change of -0.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for NEUE. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NEUE Analyst Ratings
0
Buy
1
Hold
1
Sell
NEUE Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $6.75
Latest NEUE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NEUE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 9, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $7.00 |
| Mar 13, 2024 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $8.00 |
| Aug 30, 2023 | Morgan Stanley | Underweight | Maintains | $N/A | |
| Aug 14, 2023 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Jun 30, 2023 | Nephron Research | Buy | Upgrade | $N/A | |
| Jun 15, 2023 | Barclays | Underweight | Downgrade | $N/A | |
| May 30, 2023 | RBC Capital | Sector Perform | Maintains | $N/A | |
| May 23, 2023 | Morgan Stanley | Underweight | Maintains | $N/A | |
| May 22, 2023 | Morgan Stanley | Underweight | Maintains | $N/A |
NeueHealth Inc. (NEUE) Competitors
The following stocks are similar to NeueHealth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
NeueHealth Inc. (NEUE) Financial Data
NeueHealth Inc. has a market capitalization of $60.94M with a P/E ratio of 1.2x. The company generates $890.44M in trailing twelve-month revenue with a -9.2% profit margin.
Revenue growth is -7.5% quarter-over-quarter, while maintaining an operating margin of +6.8% and return on equity of +48.3%.
Valuation Metrics
Market Cap
$60.94M
Enterprise Value
$1.10B
P/E Ratio
1.2x
PEG Ratio
0.0x
Price/Sales
0.1x
Growth & Margins
Revenue Growth (YoY)
-7.5%
Gross Margin
+30.0%
Operating Margin
+6.8%
Net Margin
-9.2%
EPS Growth
-7.5%
Financial Health
Cash/Price Ratio
+239.7%
Current Ratio
0.7x
Debt/Equity
-0.5x
ROE
+48.3%
ROA
-2.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
NeueHealth Inc. (NEUE) Business Model
About NeueHealth Inc.
What They Do
Provides innovative solutions for improved healthcare outcomes.
Business Model
NeueHealth Inc. generates revenue through a range of services including healthcare management, medical billing, and consulting, all aimed at enhancing the efficiency and quality of care provided by healthcare providers. By focusing on value-based healthcare, the company positions itself as a strategic partner for hospitals, clinics, and insurance companies, helping them optimize operations while transitioning to more sustainable models.
Additional Information
The company's emphasis on technology integration allows it to impact various sectors within the healthcare industry, contributing to improved data accuracy and streamlined processes. NeueHealth Inc. is well-positioned to play a significant role in the ongoing evolution of healthcare management and delivery systems, aligning with the industry's shift towards patient-centered care.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
986
CEO
Mr. George Lawrence Mikan III
Country
United States
IPO Year
2021
Website
www.neuehealth.comNeueHealth Inc. (NEUE) Latest News & Analysis
Latest News
Quick Summary
NeueHealth, Inc. (NYSE: NEUE) has completed its merger with an affiliate of New Enterprise Associates at an enterprise value of approximately $1.465 billion.
Why It Matters
The successful merger of NeueHealth with NEA at a $1.465 billion valuation signals potential growth and strategic shifts in the healthcare sector, impacting stock performance and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript
10 months ago
Quick Summary
NeueHealth, Inc. (NYSE:NEUE) will hold its Q2 2025 earnings conference call on August 7, 2025, at 8:00 AM ET, featuring CEO George Mikan and CFO Jay Matushak.
Why It Matters
NeueHealth's Q2 earnings call indicates upcoming financial performance insights, which can influence stock valuation, investor sentiment, and market movements.
Source: Seeking Alpha
Market Sentiment:
Neutral
NeueHealth Reports Second Quarter 2025 Results
10 months ago
Quick Summary
NeueHealth, Inc. (NYSE: NEUE) reported strong Q2 2025 financial results, achieving its sixth consecutive quarter of Adjusted EBITDA profitability.
Why It Matters
NeueHealth's consistent positive financial performance and sixth consecutive quarter of Adjusted EBITDA profitability signal strong operational momentum, enhancing investor confidence and potential for growth.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
NeueHealth, Inc. (NYSE: NEUE) will report Q2 financial results on August 7, 2025, before market open, followed by a conference call at 8:00 AM ET. Pre-registration is required for telephone participation.
Why It Matters
NeueHealth's upcoming financial results and conference call may influence stock performance, providing insights into its operational health and future growth prospects.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
NeueHealth, Inc (NYSE:NEUE) will hold its Q1 2025 earnings conference call on May 8, 2025, at 8:00 AM ET, featuring CEO Mike Mikan and CFO Jay Matushak.
Why It Matters
The earnings call indicates financial performance insights for NeueHealth, which can influence stock price and investor sentiment based on results and forecasts provided.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
NeueHealth (NYSE: NEUE) reported strong Q1 2025 results, showing growth in consumer base and achieving Adjusted EBITDA profitability, indicating a successful start to the year.
Why It Matters
NeueHealth's strong Q1 2025 results and Adjusted EBITDA profitability highlight growth potential and operational efficiency, signaling a positive outlook for investors in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About NEUE Stock
What is NeueHealth Inc.'s (NEUE) stock forecast for 2026?
Analyst forecasts for NeueHealth Inc. (NEUE) are not currently available. The stock is trading at $6.75.
Is NEUE stock a good investment in 2026?
According to current analyst ratings, NEUE has 0 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $6.75. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NEUE stock?
Price predictions from Wall Street analysts for NEUE are not currently available. The stock is trading at $6.75.
What is NeueHealth Inc.'s business model?
NeueHealth Inc. generates revenue through a range of services including healthcare management, medical billing, and consulting, all aimed at enhancing the efficiency and quality of care provided by healthcare providers. By focusing on value-based healthcare, the company positions itself as a strategic partner for hospitals, clinics, and insurance companies, helping them optimize operations while transitioning to more sustainable models.
What is the highest forecasted price for NEUE NeueHealth Inc.?
Price targets from Wall Street analysts for NEUE are not currently available. The stock is trading at $6.75.
What is the lowest forecasted price for NEUE NeueHealth Inc.?
Price targets from Wall Street analysts for NEUE are not currently available. The stock is trading at $6.75.
What is the overall NEUE consensus from analysts for NeueHealth Inc.?
The overall analyst consensus for NEUE is neutral. Out of 2 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 1 as Sell.
How accurate are NEUE stock price projections?
Stock price projections, including those for NeueHealth Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 14, 2026 5:41 PM UTC